期刊文献+

血液透析滤过治疗慢性肾功能衰竭临床疗效观察 被引量:10

下载PDF
导出
摘要 目的观察血液透析滤过治疗慢性肾功能衰竭的临床疗效。方法 76例慢性肾功能衰竭患者,分为:血液透析滤过治疗组(治疗组)和血液透析治疗组(对照组)各38例。对照组采用血液透析,每周3次,每次4小时;治疗组采用血液透析,每周2次,每次4小时及One-line血液透析滤过每周1次,每次4小时,均治疗3个月。结果两组患者治疗后血肌酐、尿素氮较治疗前均明显降低,在降低甲状旁腺激素、β2-微球蛋白方面,治疗组较对照组有明显疗效。结论血液透析滤过治疗较单纯血液透析治疗能较好地降低患者体内血肌酐、尿素氮、甲状旁腺激素、β2-微球蛋白等毒素。
作者 俞承权 刘锋
出处 《中国医药指南》 2012年第9期469-470,共2页 Guide of China Medicine
  • 相关文献

参考文献3

二级参考文献8

  • 1Ebel H,Laage C,Keuchel M,et al.Impact of profile haemodialysis on intra-extracellular fluid shifts and the release of vasoactive hormones in elderly patients on regular dialysis treatment[J].Nephron,1997,75:264-271.
  • 2Villarroel F,Ciarkowski AA.A survey on hypersensitivity reactions in hemodialysis[J].Artif Organs,1985,9:231-238.
  • 3Daugirdas JT,Ing TS.First-use reactions during hemodialysis:a definition of subtypes[J].Kidney Int Suppl,1988,24:S37-43.
  • 4Verresen L,Fink E,Lemke HD,et al.Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with N69 membranes[J].Kidney Int,1994,45:1497-1503.
  • 5Tisler A,Akocsi K,Harshegyi I,et al.Comparison of dialysis and clinical characteristics of patients with frequent and occasional hemodialysis-associated hypotension[J].Kidney Blood Press Res,2002,25:97-102.
  • 6Wolkotte C,Hassell DR,Moret K,et al.Blood volume controlled hemodialysis in hypotension-prone patients:a randomized,multicenter controlled trial[J].Kidney Int,2002,62:1034-1045.
  • 7Cruz DN,Mahnensmith RL,Brickel HM,et al.Midodrine and cool dialysate are effective therapies for symptomatic intradialytic hypotension[J].Am J Kidney Dis,1999,33:920-926.
  • 8Cruz DN,Mahnensmith RL,Brickel HM,et al.Midodrine is effective and safe therapy for intradialytic hypotension over 8 months of follow-up[J].Clin Nephrol,1998,50:101-107.

共引文献58

同被引文献47

  • 1崔红利,李伟.慢性肾功能衰竭治疗研究[J].工企医刊,2007,20(3):24-26. 被引量:2
  • 2让文军.慢性肾功能衰竭[M].北京:科学技术出版社,2006:15.
  • 3Eknoyan G, Beek GJ, Cheung AK, et al. Effect of dialysis dose andmem- brane flux in maintenance hemodialysis [ J ]. J N Engl Med, 2002,347 (25):2010 -2011.
  • 4Scholze A, Rattensperger D,Zidek W, et al. Low serum leptin pre- dicts mortality in patients with chronic kidney disease stage [ J ]. O- besity,2007,5 (6) : 1617 - 1622.
  • 5Gejyo F, Kawaguchi Y, Hara S, et al. Arresting dialysis-related amy- loidosis : A prospective multicenter controlled trial of direct hemoper- fusion with a beta 2-microglobulin adsorption column [ J ]. Artif Or- gans,2004,28 (4) :371 - 380.
  • 6徐乐.三i种血液净化方法治疗慢性肾衰竭患者的疗效比较[J].医学信息,2013,26(2):476.
  • 7Menaa C,Esser E,Sprague S M. Beta 2-microglobulin stimulates os- teoclast formation[ J]. Kidney Int ,2008,73 ( 11 ) : 1275 - 1281.
  • 8LOREE H M, AGYAPONG G, FAVREAU E G, et al.In Vitro Study of a Medical Device to Enhance Arteriovenous Fistula Eligibility and Maturation[J].ASAIO J, 2015,61 (4) : 480-486.
  • 9刘金凤,缪立英,何小舟,王惠.不同血液净化方法清除血清β2-微球蛋白的效果观察及护理[J].护理研究(上旬版),2009(8):2004-2006. 被引量:3
  • 10张秀安,吴彼得,连学坚,陈文腾,陈珊莹.血液透析及与血液透析滤过联合治疗尿毒症顽固性高血压疗效比较[J].现代诊断与治疗,2011,22(1):19-20. 被引量:11

引证文献10

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部